Safety and Immunogenicity of Different Formulations of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto Rico: Final Results after 3 Years of Follow-Up from a Randomized, Placebo-Controlled Phase I Study

Four formulations of an investigational tetravalent dengue purified inactivated vaccine, administered as two doses one month (M) apart, were previously shown to be immunogenic and well-tolerated up to M13 of the phase I study NCT01702857. Here, we report results of the follow-up from M14 to year (Y)...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Trop Med Hyg
Autors principals: Diaz, Clemente, Koren, Michael, Lin, Leyi, Martinez, Luis J., Eckels, Kenneth H., Campos, Maribel, Jarman, Richard G., De La Barrera, Rafael, Lepine, Edith, Febo, Irma, Vaughn, David W., Wilson, Todd M., Paris, Robert M., Schmidt, Alexander C., Thomas, Stephen J.
Format: Artigo
Idioma:Inglês
Publicat: The American Society of Tropical Medicine and Hygiene 2020
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7204593/
https://ncbi.nlm.nih.gov/pubmed/32124728
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.19-0461
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars